-
1
-
-
0033370270
-
Pulsed estrogen therapy: Pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations
-
Devissaguet JP, Brion N, Lhote O, et al. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet 1999;24:265-71
-
(1999)
Eur J Drug Metab Pharmacokinet
, vol.24
, pp. 265-271
-
-
Devissaguet, J.P.1
Brion, N.2
Lhote, O.3
-
2
-
-
0033535760
-
Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: Randomised dose-response study
-
Aerodiol Study Group
-
Studd J, Pornel B, Marton I, et al. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group. Lancet 1999;353:1574-8
-
(1999)
Lancet
, vol.353
, pp. 1574-1578
-
-
Studd, J.1
Pornel, B.2
Marton, I.3
-
3
-
-
0033741778
-
Randomized comparison of intranasal and transdermal estradiol
-
Lopes P, Merkus HM, Nauman J, et al. Randomized comparison of intranasal and transdermal estradiol. Obstet Gynecol 2000;96:906-12
-
(2000)
Obstet Gynecol
, vol.96
, pp. 906-912
-
-
Lopes, P.1
Merkus, H.M.2
Nauman, J.3
-
4
-
-
25044443657
-
Pulsed estrogen therapy prevents late postmenopausal bone loss: A 2 year placebo-controlled study
-
Palacios S, Rodowicki S, Marton I, et al. Pulsed estrogen therapy prevents late postmenopausal bone loss: a 2 year placebo-controlled study. Maturitas 2003;44(Suppl. 2):FC04,7
-
(2003)
Maturitas
, vol.44
, Issue.2 SUPPL.
-
-
Palacios, S.1
Rodowicki, S.2
Marton, I.3
-
5
-
-
25044443907
-
Improvement of postmenopausal quality of life after pulsed estrogen therapy: A 2 year placebo-controlled study
-
Pitkin J, Chetaille E, Bagger Y, et al. Improvement of postmenopausal quality of life after pulsed estrogen therapy: a 2 year placebo-controlled study. Maturitas 2003;44(Suppl. 2):FC06,7
-
(2003)
Maturitas
, vol.44
, Issue.2 SUPPL.
-
-
Pitkin, J.1
Chetaille, E.2
Bagger, Y.3
-
6
-
-
0035985473
-
The influence of the route of administration of 17beta-estradiol, intravenous (pulsed) versus oral, upon DMBA-induced mammary tumour development in ovariectomised rats
-
Kerdelhue B, Jolette J. The influence of the route of administration of 17beta-estradiol, intravenous (pulsed) versus oral, upon DMBA-induced mammary tumour development in ovariectomised rats. Breast Cancer Res Treat 2002;73:13-22
-
(2002)
Breast Cancer Res Treat
, vol.73
, pp. 13-22
-
-
Kerdelhue, B.1
Jolette, J.2
-
7
-
-
0037355797
-
Non-genomic actions of sex steroid hormones
-
Simoncini T, Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 2003;148:281-92
-
(2003)
Eur J Endocrinol
, vol.148
, pp. 281-292
-
-
Simoncini, T.1
Genazzani, A.R.2
-
8
-
-
0036079134
-
Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells
-
Cavailles V, Gompel A, Portois MC, et al. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. J Mol Endocrinol 2002;28:165-75
-
(2002)
J Mol Endocrinol
, vol.28
, pp. 165-175
-
-
Cavailles, V.1
Gompel, A.2
Portois, M.C.3
-
9
-
-
25044445457
-
Genomic and non-genomic vascular regulation of nitric oxide by pulsed estradiol administration
-
Simoncini T, Manella P, Fornari L, et al. Genomic and non-genomic vascular regulation of nitric oxide by pulsed estradiol administration. Climacteric 2002;5(Suppl. 2): F-15-07
-
(2002)
Climacteric
, vol.5
, Issue.2 SUPPL.
-
-
Simoncini, T.1
Manella, P.2
Fornari, L.3
-
10
-
-
0035977594
-
Tissue specificity of sex hormones and so-called modulation of receptors and enzymes
-
Kenemans P. Tissue specificity of sex hormones and so-called modulation of receptors and enzymes. Maturitas 2001;37:145-6
-
(2001)
Maturitas
, vol.37
, pp. 145-146
-
-
Kenemans, P.1
-
11
-
-
0034466973
-
Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
-
Nilsson S, Gustafsson JA. Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res 2000;2:360-6
-
(2000)
Breast Cancer Res
, vol.2
, pp. 360-366
-
-
Nilsson, S.1
Gustafsson, J.A.2
-
12
-
-
0035866760
-
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors
-
Roger P, Sahla ME, Makela S, et al. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001;61:2537-41
-
(2001)
Cancer Res
, vol.61
, pp. 2537-2541
-
-
Roger, P.1
Sahla, M.E.2
Makela, S.3
-
13
-
-
0345382876
-
Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium
-
Forster C, Makela S, Warri A, et al. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 2002;99:15578-83
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 15578-15583
-
-
Forster, C.1
Makela, S.2
Warri, A.3
-
14
-
-
0038579655
-
Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
-
Konstantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003;39:1251-8
-
(2003)
Eur J Cancer
, vol.39
, pp. 1251-1258
-
-
Konstantinopoulos, P.A.1
Kominea, A.2
Vandoros, G.3
-
15
-
-
0034705032
-
Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus
-
Weihua Z, Saji S, Makinen S, et al. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci USA 2000;97:5936-41
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 5936-5941
-
-
Weihua, Z.1
Saji, S.2
Makinen, S.3
-
16
-
-
0036923172
-
The effect of long-term treatment with steroid hormones or tamoxifen on oestrogen receptors (alpha and beta) in the endometrium of ovariectomized cynomolgus macaques
-
Wang H, Isaksson E, Von Schoultz B, et al. The effect of long-term treatment with steroid hormones or tamoxifen on oestrogen receptors (alpha and beta) in the endometrium of ovariectomized cynomolgus macaques. J Endocrinol 2002;175:673-81
-
(2002)
J Endocrinol
, vol.175
, pp. 673-681
-
-
Wang, H.1
Isaksson, E.2
Von Schoultz, B.3
-
17
-
-
0027390853
-
Changes in rat uterine estrogen receptor messenger ribonucleic acid levels during estrogen- and progesterone-induced estrogen receptor depletion and subsequent replenishment
-
Rosser M, Chorich L, Howard E, et al. Changes in rat uterine estrogen receptor messenger ribonucleic acid levels during estrogen- and progesterone-induced estrogen receptor depletion and subsequent replenishment. Biol Reprod 1993;48:89-98
-
(1993)
Biol Reprod
, vol.48
, pp. 89-98
-
-
Rosser, M.1
Chorich, L.2
Howard, E.3
-
18
-
-
0036843608
-
Estrogen causes dynamic alterations in endothelial estrogen receptor expression
-
Ihionkhan CE, Chambliss KL, Gibson LL, et al. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res 2002;91:814-20
-
(2002)
Circ Res
, vol.91
, pp. 814-820
-
-
Ihionkhan, C.E.1
Chambliss, K.L.2
Gibson, L.L.3
-
19
-
-
0036731988
-
Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: A complex interplay between estrogen receptors alpha and beta
-
Buteau-Lozano H, Ancelin M, Lardeux B, et al. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 2002;62:4977-84
-
(2002)
Cancer Res
, vol.62
, pp. 4977-4984
-
-
Buteau-Lozano, H.1
Ancelin, M.2
Lardeux, B.3
-
20
-
-
0031759728
-
Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland
-
Mitchner NA, Garlick C, Ben Jonathan N. Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland. Endocrinology 1998;139:3976-83
-
(1998)
Endocrinology
, vol.139
, pp. 3976-3983
-
-
Mitchner, N.A.1
Garlick, C.2
Ben Jonathan, N.3
-
21
-
-
0035157596
-
Estrogen receptor specificity in the regulation of the skeleton in female mice
-
Lindberg MK, Alatalo SL, Halleen JM, et al. Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol 2001;171:229-36
-
(2001)
J Endocrinol
, vol.171
, pp. 229-236
-
-
Lindberg, M.K.1
Alatalo, S.L.2
Halleen, J.M.3
-
22
-
-
0033304993
-
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
-
Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999;140:5566-78
-
(1999)
Endocrinology
, vol.140
, pp. 5566-5578
-
-
Hall, J.M.1
McDonnell, D.P.2
-
23
-
-
0037434618
-
Selective estrogen-receptor modulators - Mechanisms of action and application to clinical practice
-
Riggs BL, Hartmann LC. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003;348:618-29
-
(2003)
N Engl J Med
, vol.348
, pp. 618-629
-
-
Riggs, B.L.1
Hartmann, L.C.2
-
24
-
-
0036284103
-
Minireview: Nuclear receptor coactivators - An update
-
McKenna NJ, O'Malley BW. Minireview: nuclear receptor coactivators - an update. Endocrinology 2002;143:2461-5
-
(2002)
Endocrinology
, vol.143
, pp. 2461-2465
-
-
McKenna, N.J.1
O'Malley, B.W.2
-
25
-
-
0035987204
-
Catechol-o-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis
-
Zhu BT. Catechol-o-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 2002;3:321-49
-
(2002)
Curr Drug Metab
, vol.3
, pp. 321-349
-
-
Zhu, B.T.1
-
26
-
-
0037320432
-
2-Methoxyestradiol, a promising anticancer agent
-
Lakhani NJ, Sarkar MA, Venitz J, et al. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003;23:165-72
-
(2003)
Pharmacotherapy
, vol.23
, pp. 165-172
-
-
Lakhani, N.J.1
Sarkar, M.A.2
Venitz, J.3
-
27
-
-
0034920692
-
2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: A potential follicular antiangiogenic regulator
-
Shang W, Konidari I, Schomberg DW. 2-Methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol Reprod 2001;65:622-7
-
(2001)
Biol Reprod
, vol.65
, pp. 622-627
-
-
Shang, W.1
Konidari, I.2
Schomberg, D.W.3
-
28
-
-
0037342726
-
CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs
-
Dubey RK, Gillespie DG, Zacharia LC, et al. CYP450- and COMT-denrived estradiol metabolites inhibit activity of human coronary artery SMCs. Hypertension 2003;41:807-13
-
(2003)
Hypertension
, vol.41
, pp. 807-813
-
-
Dubey, R.K.1
Gillespie, D.G.2
Zacharia, L.C.3
-
29
-
-
0642287656
-
Medical hypothesis: Hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer
-
Zhu BT. Medical hypothesis: Hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. Int J Oncol 2003;22:499-508
-
(2003)
Int J Oncol
, vol.22
, pp. 499-508
-
-
Zhu, B.T.1
-
30
-
-
0034007347
-
Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: Studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites
-
Tsutsui Y, Tamura Y, Yagi E, et al. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites. Int J Cancer 2000;86:8-14
-
(2000)
Int J Cancer
, vol.86
, pp. 8-14
-
-
Tsutsui, Y.1
Tamura, Y.2
Yagi, E.3
|